StockGlow

Seer, Inc. (SEER)

Builds machines and software that analyze proteins in biological samples for research labs.

$2.09+0.06%Healthcare
Compare SEER with
StockGlow Score
82
Bullish
BearishBullish
1 year ago-2.1%

The outlook

SEER is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. Analyst targets average around 92% above the current price, suggesting meaningful gap between where the stock trades now and where coverage sees it valued. The overall sentiment leans bullish based on current data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Price targetAvg target +92% vs current price
Market cap
$114.6M
52-wk high
$2.41
52-wk low
$1.55
50-day avg
$1.87
200-day avg
$1.91
Trailing P/E
—

Similar stocks

BCABBioAtla, Inc.$3.35-1.47%PRLDPrelude Therapeutics Incorporated$4.27+9.77%MASS908 Devices Inc.$7.03-1.40%CGEMCullinan Therapeutics, Inc.$17.58+0.86%CERTCertara, Inc.$7.97+2.77%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy